56 forecasters

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

1%chance

Forecast Timeline

No key factors yetAdd some that might influence this forecast.

Add key factor

Authors:

Opened:

Nov 24, 2021

Closes:

Dec 31, 2026

Scheduled resolution:

Jan 1, 2027

Spot Scoring Time:

Nov 26, 2021

Health & Pandemics

New ‘unusual’ side effect of weight-loss drugs becoming more common, research suggests

Independent•Oct 17, 2025

Ozempic and Wegovy might help slow how fast you get drunk, new research finds

Independent•Oct 16, 2025

Are you ‘Ozempic sober’? GLP-1s are making users feel less drunk

New York Post•Oct 15, 2025

Learn more about Metaculus NewsMatch